12.33
price up icon6.20%   0.72
after-market Dopo l'orario di chiusura: 12.33
loading
Precedente Chiudi:
$11.61
Aprire:
$11.65
Volume 24 ore:
425.67K
Relative Volume:
1.51
Capitalizzazione di mercato:
$382.88M
Reddito:
-
Utile/perdita netta:
$-47.20M
Rapporto P/E:
-7.8771
EPS:
-1.5653
Flusso di cassa netto:
$-43.65M
1 W Prestazione:
+3.53%
1M Prestazione:
-6.16%
6M Prestazione:
-32.44%
1 anno Prestazione:
+0.00%
Intervallo 1D:
Value
$11.47
$12.42
Intervallo di 1 settimana:
Value
$10.30
$12.51
Portata 52W:
Value
$4.8069
$27.50

Mbx Biosciences Inc Stock (MBX) Company Profile

Name
Nome
Mbx Biosciences Inc
Name
Telefono
(317) 989-3100
Name
Indirizzo
11711 N. MERIDIAN STREET, CARMEL
Name
Dipendente
43
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
MBX's Discussions on Twitter

Confronta MBX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
MBX
Mbx Biosciences Inc
12.33 382.88M 0 -47.20M -43.65M -1.5653
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Mbx Biosciences Inc Stock (MBX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-10 Iniziato Citizens JMP Mkt Outperform
2024-10-08 Iniziato Guggenheim Buy
2024-10-08 Iniziato JP Morgan Overweight
2024-10-08 Iniziato Jefferies Buy
2024-10-08 Iniziato Stifel Buy

Mbx Biosciences Inc Borsa (MBX) Ultime notizie

pulisher
Jun 18, 2025

Strategic Growth and Clinical Advancements Propel MBX Biosciences to a Buy Rating - TipRanks

Jun 18, 2025
pulisher
Jun 17, 2025

MBX Biosciences files IND application for MBX-4291 for obesity - BioWorld MedTech

Jun 17, 2025
pulisher
Jun 16, 2025

MBX Biosciences announces IND application to FDA for MBX 4291 - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

MBX Biosciences Submits IND for Obesity Treatment - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

MBX Biosciences submits IND for once-monthly obesity treatment - Investing.com

Jun 16, 2025
pulisher
Jun 16, 2025

MBX Biosciences Announces IND Submission Of MBX 4291, Its Long-Acting GLP1/GIP Receptor Co-Agonist Prodrug For The Treatment Of Obesity - MarketScreener

Jun 16, 2025
pulisher
Jun 16, 2025

MBX Biosciences Announces IND Submission of MBX 4291, its - GlobeNewswire

Jun 16, 2025
pulisher
Jun 16, 2025

MBX Biosciences Announces IND Submission of MBX 4291, its Long-acting GLP1/GIP Receptor ... - Eagle-Tribune

Jun 16, 2025
pulisher
Jun 14, 2025

Bank of America Corp DE Makes New Investment in MBX Biosciences, Inc. (NYSE:MBX) - Defense World

Jun 14, 2025
pulisher
Jun 12, 2025

Stifel reiterates buy rating on MBX Biosciences stock ahead of trial data - Investing.com Nigeria

Jun 12, 2025
pulisher
Jun 12, 2025

Stifel reiterates buy rating on MBX Biosciences stock ahead of trial data By Investing.com - Investing.com South Africa

Jun 12, 2025
pulisher
Jun 10, 2025

MBX Biosciences Announces Presentations on MBX 1416 at American Diabetes Association’s 85th Scientific Sessions - Nasdaq

Jun 10, 2025
pulisher
Jun 10, 2025

MBX Biosciences to Present at the American Diabetes Association 85th Scientific Sessions - GlobeNewswire

Jun 10, 2025
pulisher
Jun 10, 2025

MBX Biosciences Phase 1 Success: Revolutionary Weekly Treatment for Post-Bariatric Hypoglycemia Heads to Phase 2 - Stock Titan

Jun 10, 2025
pulisher
Jun 09, 2025

MBX Biosciences Updates Corporate Presentation June 2025 - TipRanks

Jun 09, 2025
pulisher
Jun 07, 2025

Nuveen Asset Management LLC Purchases Shares of 14,471 MBX Biosciences, Inc. (NYSE:MBX) - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

BNP Paribas Financial Markets Makes New Investment in MBX Biosciences, Inc. (NYSE:MBX) - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

mbx biosciences announces board changes and director elections - Investing.com Australia

Jun 06, 2025
pulisher
Jun 06, 2025

mbx biosciences announces board changes and director elections By Investing.com - Investing.com South Africa

Jun 06, 2025
pulisher
Jun 06, 2025

MBX Biosciences, Inc. Announces Departure of Carl L. Gordon from the Company's Board of Directors, Effective June 5, 2025 - marketscreener.com

Jun 06, 2025
pulisher
Jun 06, 2025

MBX Biosciences Elects Directors at Annual Meeting - TipRanks

Jun 06, 2025
pulisher
Jun 04, 2025

Deutsche Bank AG Buys New Position in MBX Biosciences, Inc. (NYSE:MBX) - Defense World

Jun 04, 2025
pulisher
Jun 02, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases Shares of 6,335 MBX Biosciences, Inc. (NYSE:MBX) - Defense World

Jun 02, 2025
pulisher
May 31, 2025

MBX Biosciences: Consider Peptide Developer With GLP Drugs As A Speculative Buy - Seeking Alpha

May 31, 2025
pulisher
May 30, 2025

MBX Biosciences, Inc. (NYSE:MBX) Given Consensus Rating of “Buy” by Brokerages - Defense World

May 30, 2025
pulisher
May 28, 2025

MBX Biosciences, Inc. (NYSE:MBX) Shares Sold by Millennium Management LLC - Defense World

May 28, 2025
pulisher
May 27, 2025

Northern Trust Corp Invests $1.67 Million in MBX Biosciences, Inc. (NYSE:MBX) - Defense World

May 27, 2025
pulisher
May 20, 2025

MBX Biosciences to Participate in June Investor Conferences - GlobeNewswire

May 20, 2025
pulisher
May 20, 2025

MBX Biosciences Showcases Precision Peptide Pipeline at Two Major Healthcare Conferences This June - Stock Titan

May 20, 2025
pulisher
May 19, 2025

Citadel Advisors LLC Grows Stock Holdings in MBX Biosciences, Inc. (NYSE:MBX) - Defense World

May 19, 2025
pulisher
May 15, 2025

MBX Biosciences, Inc. (NYSE:MBX) Shares Acquired by The Manufacturers Life Insurance Company - Defense World

May 15, 2025
pulisher
May 14, 2025

MBX Biosciences Reports Q1 2025 Financial Progress - TipRanks

May 14, 2025
pulisher
May 13, 2025

MBX Biosciences, Inc.: Strong Buy Rating Amid Promising Phase II Data and Robust Financial Position - TipRanks

May 13, 2025
pulisher
May 12, 2025

Stifel maintains MBX Biosciences stock Buy rating, $40 target By Investing.com - Investing.com Nigeria

May 12, 2025
pulisher
May 12, 2025

Stifel maintains MBX Biosciences stock Buy rating, $40 target - Investing.com

May 12, 2025
pulisher
May 12, 2025

MBX Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 12, 2025
pulisher
May 12, 2025

MBX Biosciences Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - The Manila Times

May 12, 2025
pulisher
May 12, 2025

Wells Fargo & Company MN Purchases Shares of 5,844 MBX Biosciences, Inc. (NYSE:MBX) - Defense World

May 12, 2025
pulisher
May 09, 2025

Hypoglycemia Market Poised for Notable Growth by 2032, Fueled - openPR.com

May 09, 2025
pulisher
May 05, 2025

MBX Biosciences Up 28%, Insider Buyers Are Up 19% - simplywall.st

May 05, 2025
pulisher
May 05, 2025

MBX Biosciences, Inc. (NYSE:MBX) Receives Consensus Rating of “Buy” from Analysts - Defense World

May 05, 2025
pulisher
Apr 27, 2025

MBX Biosciences, Inc. (NYSE:MBX) Shares Purchased by Geode Capital Management LLC - Defense World

Apr 27, 2025
pulisher
Apr 23, 2025

JMP maintains MBX Biosciences stock $38 target, upbeat on trial data - Investing.com Australia

Apr 23, 2025
pulisher
Apr 23, 2025

Companies Like MBX Biosciences (NASDAQ:MBX) Are In A Position To Invest In Growth - Yahoo Finance

Apr 23, 2025
pulisher
Apr 22, 2025

MBX Biosciences to Participate in Citizens and RBC May Investor Conferences - The Manila Times

Apr 22, 2025
pulisher
Apr 22, 2025

MBX Biosciences Reveals Growth Strategy at Citizens and RBC Healthcare Conferences: Key Updates Coming - Stock Titan

Apr 22, 2025

Mbx Biosciences Inc Azioni (MBX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Mbx Biosciences Inc Azioni (MBX) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
GORDON CARL L
Director
Feb 18 '25
Buy
10.84
143,170
1,551,963
3,255,000
GORDON CARL L
Director
Feb 14 '25
Buy
9.87
47,502
468,793
3,205,930
ORBIMED ADVISORS LLC
Director
Feb 18 '25
Buy
10.84
143,170
1,551,963
3,255,000
ORBIMED ADVISORS LLC
Director
Feb 14 '25
Buy
9.87
47,502
468,793
3,205,930
Hawryluk P. Kent
President & CEO
Feb 04 '25
Buy
10.69
50,000
534,500
448,277
Mathers Edward T
Director
Sep 16 '24
Buy
16.00
500,000
8,000,000
3,614,486
BASKETT FOREST
10% Owner
Sep 16 '24
Buy
16.00
500,000
8,000,000
3,614,486
Behbahani Ali
10% Owner
Sep 16 '24
Buy
16.00
500,000
8,000,000
3,614,486
Chang Carmen
10% Owner
Sep 16 '24
Buy
16.00
500,000
8,000,000
3,614,486
Florence Anthony A. Jr.
10% Owner
Sep 16 '24
Buy
16.00
500,000
8,000,000
3,614,486
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Capitalizzazione:     |  Volume (24 ore):